TE VA 7630 Pill: brown , capsule/oblong, 19mm
The pill with imprint TE VA 7630 (Brown, Capsule/Oblong1) has been identified as Imatinib Mesylate 400 mg and is used for Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Eosinophilic Leukemia, Dermatofibrosarcoma Protuberans, and Gastrointestinal Stromal Tumor. It belongs to the drug class BCR-ABL tyrosine kinase inhibitors and is not a controlled substance.
Images for TE VA 7630
Imatinib Mesylate
- Imprint
- TE VA 7630
- Strength
- 400 mg
- Color
- Brown
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00093-7630
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
FD&C Yellow No. 6,
hypromellose 2910 (6 mPa.s),
ferric oxide yellow,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
sodium stearyl fumarate,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
See also:
More about imatinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (47)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.